Home Global Health Policy Topics

Global Health Policy

New and Noteworthy

Analysis of USAID’s Active and Terminated Awards List: How Many Are Global Health?

This data note analyzes the list of terminated and active awards the Trump Administration recently sent to Congress highlighting to assess the impact on global health awards.

An Update on PEPFAR Reauthorization

Overview of President Trump’s Executive Actions on Global Health

The Trump Administration’s Foreign Aid Freeze and Global Health: The Biggest Gaps Left on the Donor Landscape

The Pause of Foreign Aid and Implications for PEPFAR and Other Global Health Programs

selected resources

Global Health Aid Cuts

This collection of resources chronicles what recent Trump administration global health aid cuts mean for the future of global health programs and the people who rely on them.

A promotional image for the the KFF Health Policy 101 U.S. Government and Global Health

The U.S. Government and Global Health

In this Health Policy 101 chapter, investigate the U.S. role in global health, including the major initiatives the United States supports, funding levels, and agencies involved in implementing program area efforts.

the essentials
global health trackers

Latest News

More KFF Health News

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

View the Latest: Global Health Policy

Filter

List Grid

111 - 120 of 607 Results

  • PEPFAR May Improve Key Economic and Educational Outcomes, Not Just Health Outcomes

    News Release

    A new KFF analysis finds that the President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. global HIV/AIDS response and the largest commitment by any nation to address a single disease in history, is associated with improvements in key economic and educational outcomes in countries that received PEPFAR support.

  • The COVAX Humanitarian Buffer for COVID-19 Vaccines: Review and Assessment of Policy Implications

    Issue Brief

    In this Issue Brief we review and assess the COVAX Humanitarian Buffer mechanism, which is part of the effort to share Covid vaccines globally. The Buffer is intended to direct vaccines to vulnerable people like refugees and others facing humanitarian emergencies during the pandemic, and was supported by the US and many other donors and organizations. However, it faced many challenges such as liability and indemnification issues for using newly developed vaccines, restricted access to vaccines and funding, and difficult and complex application, review, and implementation processes. We discuss these challenges and also consider implications of the Buffer experience for future pandemic preparedness and response efforts.

  • Donor Government Funding for Family Planning in 2021

    Report

    In 2021, donor government funding for family planning activities totaled US$1.39 billion, essentially flat compared to the 2020 amount (US$1.41 billion). This report provides an analysis of donor government funding to address family planning in low- and middle-income countries in 2021.

  • Analysis: There is Significant Variation in State and Local Eligibility Criteria for Monkeypox Vaccines, and Vaccine Information is not Always Accessible

    News Release

    According to a new KFF analysis assessing monkeypox (MPX) vaccine eligibility across the United States, people who are exposed or presumed exposed to MPX are generally eligible to get a vaccine across the country. However, eligibility varies across the United States for certain workers, including laboratory staff and others who might be at increased risk.

  • Assessing Monkeypox (MPX) Vaccine Eligibility Across the United States

    Issue Brief

    This analysis examines jurisdictional approaches to eligibility for monkeypox (MPX) vaccine. Overall, almost all jurisdictions have, at minimum, adopted the current approach laid out by the CDC. However, there is substantial variation in how eligibility is defined. Additionally, several jurisdictions lack clear criteria or information on who is eligible or where to get vaccinated. This may impact on who gets vaccinated, lead to geographic disparities, and raises potentially equity challenges.

  • PEPFAR and Sustained Epidemic Control

    Issue Brief

    This analysis provides an initial look at how PEPFAR is currently defining and approaching sustained epidemic control at the country level.